Nasopharyngitis

Download PDF

Recent Publications on Nasopharyngitis:
Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials. BACKGROUND: Although griseofulvin is currently considered the primary...	4th July, 2008	Department of Dermatology, University of Alabama, Birmingham, Alabama	J Am Acad Dermatol. 2008 Jul;59(1):41-54. Epub 2008 Apr 18. DOI Direct Link
Aliskiren. PURPOSE: The pharmacology, bioavailability and pharmacokinetics, clinical...	3rd July, 2008	Department of Clinical and Administrative Sciences, Sullivan University	Am J Health Syst Pharm. 2008 Jul 15;65(14):1323-32. DOI Direct Link
Telbivudine for the management of chronic hepatitis B virus infection. BACKGROUND: Telbivudine (LdT) is an L-nucleoside that is structurally...	2nd July, 2008	Division of Clinical Pharmacy, Department of Pharmacy Practice, School of	Clin Ther. 2007 Dec;29(12):2635-53. DOI Direct Link
Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). BACKGROUND: This study examined the efficacy and safety of quetiapine in...	27th June, 2008	Clinical Institute of Neuroscience, Hospital Clinic, University of	J Affect Disord. 2008 Aug;109(3):251-263. Epub 2008 Jun 24. DOI Direct Link
Ambrisentan for the management of pulmonary arterial hypertension. Background: Approved by the US Food and Drug Administration in 2007,...	17th June, 2008	Massachusetts College of Pharmacy and Health Sciences and Brigham and	Clin Ther. 2008 May;30(5):825-33. DOI Direct Link
→View more research publications.

BioNews Results for Nasopharyngitis:
Eltrombopag Demonstrates Safety and Efficacy in Idiopathic Thrombocytopenic Purpura: Presented at EHA	Doctors Guide:  Jun 14 2008 2:05AM Matching: nasopharyngitis
A New Analysis Released at ADA: Lower Risk of Symptomatic Hypoglycemia with JANUVIA(TM) (sitagliptin) Compared	Genetic Engineering News:  Jun 10 2008 3:51AM Matching: nasopharyngitis
New Data Released at Major Diabetes Meeting on Initial Combination Therapy with JANUVIA(TM) (sitagliptin), Mer	Genetic Engineering News:  Jun 8 2008 9:48PM Matching: nasopharyngitis
New Data Released at Major Diabetes Meeting on Initial Combination Therapy with JANUVIA(TM) (sitagliptin), Mer	Genetic Engineering News:  Jun 8 2008 9:38AM Matching: nasopharyngitis

Nasopharyngitis Patents:
US Patent No.	Title
4138486	Arylmalonamido-1-oxadethiacephalosporins
4523589	Method and apparatus for treating ailments
4525355	7-.beta.-Ureidoacetamido-oxacephalosporins
4529721	Vinylthioacetamido oxacephalosporin derivatives
4529722	Oxacephalosporin derivatives
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Nasopharyngitis scientists - we have details of around 34 individuals working on Nasopharyngitis .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.